Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXPI | Common Stock | Options Exercise | $630 | +9K | +0.02% | $0.07* | 42M | Dec 14, 2021 | Direct | |
transaction | EXPI | Common Stock | Sale | -$175K | -5.31K | -0.01% | $32.91 | 42M | Dec 14, 2021 | Direct | F1, F2 |
transaction | EXPI | Common Stock | Sale | -$123K | -3.69K | -0.01% | $33.39 | 42M | Dec 14, 2021 | Direct | F1, F3 |
transaction | EXPI | Common Stock | Options Exercise | $630 | +9K | +0.02% | $0.07* | 42M | Dec 15, 2021 | Direct | |
transaction | EXPI | Common Stock | Sale | -$151K | -4.67K | -0.01% | $32.39 | 42M | Dec 15, 2021 | Direct | F1, F4 |
transaction | EXPI | Common Stock | Sale | -$55K | -1.65K | 0% | $33.32 | 42M | Dec 15, 2021 | Direct | F1, F5 |
transaction | EXPI | Common Stock | Sale | -$92.5K | -2.68K | -0.01% | $34.54 | 42M | Dec 15, 2021 | Direct | F1, F6 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXPI | Stock Options (Right to buy) | Options Exercise | $0 | -9K | -0.54% | $0.00 | 1.67M | Dec 14, 2021 | Common Stock | 9K | $0.07 | Direct | F7 |
transaction | EXPI | Stock Options (Right to buy) | Options Exercise | $0 | -9K | -0.54% | $0.00 | 1.66M | Dec 15, 2021 | Common Stock | 9K | $0.07 | Direct | F7 |
Id | Content |
---|---|
F1 | The sale reported in this Form 4 was effected pursuant to a preexisting Rule 10b5-1 trading plan adopted by the reporting person. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.20 to $33.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.20 to $33.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.01 to $32.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.01 to $33.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $34.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F7 | The option grant is fully vested. |